Abstract:Objective To study the distribution of fungal species in otomycosis and detect the drug sensitivity of pathogenic bacteria to antifungal drugs.Methods In this study, 239 patients with otomycosis were collected, who were treated in Department of Otolaryngology Head and Neck Surgery, Jingzhou Central Hospital from April 2020 to November 2021. Fungal species were identified by morphological examination, sand glucose solid medium (SDA) for fungal culture, DNA extraction, PCR amplification and sequencing in ITS region. Minimum inhibitory concentration (MIC) of bibenbenzazole (PCB), terbinafine (TRB), clotrimazole (CLO) and itraconazole (ITR) were determined by minimum inhibitory concentration test.Results Most of the pathogenic bacteria was Aspergillus in otomycosis. Aspergillus terreus was the most common pathogen of otomycosis, followed by Aspergillus Niger, Aspergillus flavus and candida. Most of the pathogenic bacteria causing otomycosis were resistant to PCB and CLO (MIC > 16 μg/ mL), and most of the pathogenic bacteria were sensitive to TRB and ITR. Therefore, ITR and TRB drugs should be the first choice in the treatment of otomycosis.Conclusions Aspergillus and Candida are the most common fungal pathogens of otomycosis. ITR and TRB are the first choice drugs for the treatment of otomycosis.